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Abstract: In this paper, label-free biosensing for antibody screening by periodic lattices of 
high-aspect ratio SU-8 nano-pillars (BICELLs) is presented. As a demonstration, the 
determination of anti-gestrinone antibodies from whole rabbit serum is carried out, and for 
the first time, the dissociation constant (KD = 6 nM) of antigen-antibody recognition 
process is calculated using this sensing system. After gestrinone antigen immobilization on 
the BICELLs, the immunorecognition was performed. The cells were interrogated 
vertically by using micron spot size Fourier transform visible and IR spectrometry  
(FT-VIS-IR), and the dip wavenumber shift was monitored. The biosensing assay exhibited 
good reproducibility and sensitivity (LOD = 0.75 ng/mL). 
OPE N A C C ESS 
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1. Introduction 
The development of powerful analytical tools has undergone a significant advance in the last years. 
Nevertheless, new improvements capable of ensuring affordable, rapid, reproducible, and sensitive 
analyses in a cost-effective way are mandatory for a broad range of application fields, such as 
healthcare, food safety, defense, environment or drug control. Among biosensing techniques, 
immunoassays are widely used for diagnostic testing and monitoring. They are based on the specific 
affinity reaction of antibodies to antigens. Generally, excellent values of sensitivity, specificity, and 
short reaction times, which are essential factors, are achieved by this methodology [1]. Detection based 
on immunoassay is used in many different devices and technologies such as reactive strips, ELISA or 
flow cytometry [1]. 
Immunoassays can be classified according to different criteria. As for the type of detection,  
one can distinguish between immunoassays requiring external markers to detect binding (labeled 
immunoassays) and those that do not need these markers (label-free immunoassays). The first ones 
show several drawbacks such as preparation of tracers, limited flexibility, and additional development 
steps. Label-free immunoassays display advantages such as cost-effectiveness, short analysis time, and 
operational simplicity. Interestingly, in many optical label-free biosensors, the biological reaction can 
be detected by a refractive index change. 
Remarkable results have been accomplished through optical label-free biosensors [2,3], highlighting 
surface plasmon resonance (SPR) [4±6], porous silicon [7,8] and slot-waveguide resonators [9] based 
biosensors, Mach-Zehnder interferometers [10,11], directional couplers [12], and micro-ring [13] and 
disk [14] resonators. 
Recently, we demonstrated label-free biosensing by means of SU-8 nano-pillars arrays [15],  
which were named BICELLs (Biophotonic sensing cells). The model system of bovine serum albumin/ 
anti-bovine serum albumin (BSA/anti-BSA) was employed to demonstrate this concept. BICELLs¶ 
structures consist of a periodic lattice of high-aspect ratio of SU-8 nano-pillars where the immobilization 
of BSA protein and the later specific recognition by anti-BSA antibodies were monitored. A limit of 
detection (LOD) of 2.3 ng/mL was achieved for aBSA recognition. At the same time, the biofilm 
thickness coating (BSA-aBSA complex) on the sensing surface of the arrays was estimated. 
For the construction of BICELLs, SU-8 was selected because of its fluidic properties [16], 
performance and compatibility with micro-nano-processing [17], high refractive index for sensing  
purposes [18], and capability for direct adsorption of biomolecules [19]. Also, the device can be 
interrogated vertically, which avoids the use of complex coupling systems and packaging, thus 
providing cost-effectiveness. The vertical optical interrogation of these nano-structures can be done 
both by reflection employing SiO2 as substrate, or by transmission, with ITO-based substrates [20]. 
Furthermore, an improvement of the sensitivity with these nano-pillars in comparison with a single 
SU-8 layer of similar thickness of the pillar height has already been demonstrated [15]. 
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Label-free detection techniques have been used for the determination of target analytes in serum, 
with no further treatment. For example, levels of anti-BSA in serum have been measured by scattering 
biophotonic microarray imaging of BSA-modified gold nanoparticles [21], with a sensitivity of  
250 ng/mL. On the other hand, for the specific determination of target species in solution, the knowledge 
of the immunoassay kinetic parameters, such as the dissociation constant KD, is very important [22]. 
In this paper we describe the label-free biosensing of anti-Gestrinone antibodies from rabbit blood 
serum and, for the first time, the BICELLs are used to determine the affinity constant of the 
immunorecognition process. Also, the affinity constant for the system BSA/anti-BSA is obtained and 
compared with already existing data in order to check the quality of performance of the measurement 
platform. Thus, the utility of the BICELLs to perform reliable estimations of the dissociation constants 
working in heterogeneous format is demonstrated. 
2. Exper imental Section 
2.1. Reagents 
SU-8 2000.5 and SU-8 developer were provided by MicroChem Corp. (Newton, MA, USA). 
Ethanolamine and sulfuric acid 95±98% were purchased from Sigma-Aldrich (Madrid, Spain). 
The buffers employed were: PBS 1× (10 mmol/L sodium phosphate, 137 mmol/L NaCl,  
2.7 mmol/L KCl, pH 7.4) and PBS-T (PBS containing 0.05% Tween 20). 
The gestrinone hapten-Horseradish peroxidase conjugate (HRP-h-G) and the anti-gestrinone 
antiserum from rabbit were synthesized as previously described [23]. 
Albumin chicken egg (OVA), Streptavidin-Atto 655, Gold-labeled goat anti-rabbit antibody  
(GAR-Au), 3,3',5,5'-tetramethylbenzidine (TMB) liquid substrate from membranes, and silver 
enhancer solutions A and B were purchased from Sigma-Aldrich (Madrid, Spain). Cy5-labeled goat 
anti-rabbit antibody (GAR-Cy5) was provided by GE Healthcare (Uppsala, Sweden). 
2.2. Experimental Techniques 
SU-8 layers were deposited on SiO2 substrates with a spin-coater; model WS-400BX-6MPP/LITE 
from Laurell Technologies Corp. (North Wales, PA, USA). The hot-plate model Agimatic E-C was 
from JP-Selecta (Barcelona, Spain). 2D periodical patterns of e-beam single-shots were performed on 
the SU-8 layers by using a CRESTEC CABL 9500 High Resolution electron-beam lithography system 
at 50 keV e-beam energy. BICELLs were optically characterized through a Fourier transform visible 
and infrared Bruker Vertex 70 spectrometer. To analyze a single BICELL, a Bruker Hyperion 1000 
microscope with an optical condenser that provides an interrogation angle of an incidence from 15° to 
22° and a magnification of 15×, was employed. Also, a confocal microscope Leica DCM3D was used 
to check the integrity of the structures. 
Microarray fluorescence measurements were obtained with a homemade surface fluorescence 
reader (SFR) equipped with a highly sensitive CCD camera [24]. 
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2.3. Experimental Procedures 
2.3.1. Nanofabrication of BICELLs 
SU-8 nano-structures were manufactured by selective e-beam exposition of certain regions followed 
by chemical development, as reported recently [25]. BICELLs consisted of 60 × 60 µm2 of rhombic 
lattices of SU-8 high-aspect ratio nano-pillars with a pitch of 800 nm. The nano-pillar size was around 
200 nm in diameter and 420 nm in height over a 1 µm thick SiO2 layer on a silicon substrate. 
2.3.2. Immobilization and Bioavailability Studies on Planar Surfaces 
For the aforementioned immobilization studies, glass slides were spin-coated with 1 mL of SU-8, 
baked and cured according to the supplier fabrication specifications. 
Different concentrations of GAR-Cy5 and streptavidin-Atto 655 (from 0 to 50 ȝg/mL) in PBS 1× 
were printed on the surface as 50 nL drops with a non-contact arrayer, creating a matrix of 1 ×3 spots 
for each concentration. The fluorescence intensity of the spots was registered using the SFR to obtain  
a standard curve for the probes. After incubating for 2 h at room temperature in a dark, humid chamber, 
planar chips were washed first 5 min with PBS-T, then 5 min with water and finally air-dried. The 
fluorescence was registered with the SFR at 635 nm. The signal intensity of the spots was quantified, 
and the amount of immobilized bioreceptor calculated from the respective calibration curve. 
Following the procedure described above, HRP-h-G dilutions at 1, 5, 10 and 20 ȝg/mL in PBS 1× 
were immobilized on planar SU-8 chips creating a matrix of 1 ×4 spots for each concentration. After 
incubating for 2 h at room temperature in a humid chamber, each chip was washed with both PBS-T 
and water, and then dried. Twenty microliters of 1% OVA or 0.1 M ethanolamine in PBS were 
deposited on the surface and spread under a coverslip. After incubating for 30 min at room 
temperature, the chip was washed 5 min with PBS-T, water and air-dried. Rabbit anti-gestrinone serum 
at different dilutions from 1/10,000 to 1/200 in PBS-T was extended over the chip using a cover slip, 
and incubated at room temperature for 10 min. After washing with PBS-T and water, the chip was 
treated with 20 ȝL of GAR-Au 1/200 in PBS-T for 10 min, washed with PBS-T, then with water and 
dried. Finally, the microarray was developed using silver enhancer solution for 10 min, until the dark 
precipitate appeared in those spots showing a positive biorecognition assay. 
2.3.3. HRP-h-G Conjugate Immobilization and Anti-Gestrinone Antibody Recognition on the BICELLs 
After fabrication, the BICELLs were treated by immersion with sulfuric acid 95±98% for 10 s 
followed by a washing with deionized water (DI)-H2O at room temperature and dried with N2. After 
that, the BICELLs were checked by confocal microscopy. 
Several HRP-h-G conjugate solutions at different concentrations ranging from 0 µg/mL to 100 µg/mL 
in PBS-T were prepared. The conjugate immobilization was performed with 20 µL for each conjugate 
concentration for 60 min. Then, the surfaces were rinsed with (DI)-H2O and blown with N2 in a clean 
environment; BICELLs were optically characterized through Fourier transform visible and infrared 
spectrometry after each HRP-h-G incubation/washing step. The temperature was controlled at 20 ± 1 °C 
and the incubation was performed in a wet atmosphere. After this, 20 µL of ethanolamine 0.1 M in 
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PBS was added to block the remaining epoxy groups on the surface and the BICELLs were washed 
and dried as before. Finally, 20 µL of rabbit antiserum dilution (ranging from 1/10,000 to 1/100) in 
PBS-T were dispensed and incubated for 60 min, then washed with (DI)-H2O and blown with N2, and 
optically characterized as aforementioned. 
3. Results and Discussion 
The schematic representation and the 3D visualization of the BICELLs used in this work are shown 
in Figure 1(a,b), and it is considered to be a rhombic lattice of SU-8 nano-pillars with 200 nm in 
diameter, 420 nm in height and a pitch between pillars of 800 nm. 
Before biosensing measurements, blank assays were carried out in order to correct the background 
signal from the SiO2 layer on the Si substrate. 
F igure 1. (a) Schematic representation of a 3D periodic array nano-pillar fabricated after 
the SU-8 spin coating deposition; (b) scanning electron microscope (SEM) micrograph of  
a SU-8 based biosensing cell. 
 
With regard to the bioreceptor surface attachment, the epoxy groups in the SU-8 polymer allow the 
direct protein immobilization by the nucleophilic attack of the protein amine moieties. Thus, the first 
stage was to study the immobilization process. To evaluate the immobilization and biorecognition 
processes, planar chips consisting of glass slides coated with a layer of SU-8 photoresist were 
employed because our previous experience with BICELLs showed that the protocols developed in 
planar substrates constituted a good starting point to be applied later in the nanostructures 
functionalization. Microarrays (3 × 3 spots) of Atto-labeled streptavidin and Cy5-labeled goat  
anti-rabbit antibody were created²ranging from 0 to 50 µg/mL²on these chips with a non-contact 
printing automatic arrayer. Different variables such as printing buffer (carbonate buffer, phosphate 
buffered saline and sodium citrate saline), incubation time (from 15 min to 16 h) and washing steps 
were analyzed to improve the protein immobilization. The best immobilization result was obtained for 
1 µg/mL of labeled probe in PBS 1× as the immobilization buffer, incubating in a humid, dark 
chamber for 1 h and washing by immersion in DI-H2O. The immobilization yield was calculated from 
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a calibration curve, as explained in the Experimental Section, resulting a 50% of a closely packed 
monolayer for both the protein [26] and the antibody [27], which corresponds to a coating density of 
3.3 and 1.0 pmol/cm2, respectively. These values were in accordance with others reported in the 
literature for protein and antibody immobilization on SU-8 [19,28]. Also, the selectivity of the 
immobilization against SiO2, the material creating the nanopillar platform, was evaluated. To this end, 
only half of the surface of the SiO2 planar chips was partially coated with SU-8, and an immobilization 
protocol was applied to both parts of the chip. After incubating and washing, the fluorescence was read 
(ESI, Table S1), observing protein immobilization only on the coated surface (Figure 2). Finally, the 
chip was washed under acidic conditions (glycine buffer, pH 2.4, 2 h), observing that the fluorescence 
in the microarrays decreased in less than 10% of the cases, indicating the robustness of the attachment 
(ESI, Table S1). 
F igure 2. Scheme of the procedure employed to test the selective antibody immobilization 
on SU-8 planar chips using microarrays and Cy5 labeling. 
 
Once the successful immobilization of bioreceptors on the SU-8 polymer was demonstrated, their 
bioavailability for a recognition event was studied. For that, the model system gestrinone/anti-gestrinone 
was employed. The synthetic steroid gestrinone has anti-estrogenic and anti-progesterone properties, 
and it is involved in several pharmacological applications including uterine pathologies [29], 
contraception [30,31], and endometriosis [32]. Due to gestrinone¶V anabolic effects, it is the only 
marketed progestin included in the banned list of performance-enhancing drugs in sports (The world  
anti-doping code, www.wada-ama.org). In our case, gestrinone oxime was used as steroid hapten 
conjugated to HRP (HRP-h-G) (Figure 3), which is more appropriate to obtain specific assays because 
antibodies are raised against a particular moiety of a selected steroid. First of all, the immobilization of 
HRP was checked using the protocol used with BSA, employing TMB as enzymatic substrate for the 
assay development. Thus, the presence of the enzyme was detected through the appearance of a dark 
blue precipitate whose intensity was proportional to the amount of immobilized HRP. 
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F igure 3. Synthesis of gestrinone oxime hapten (a) and gestrinone oxime  
hapten-horseradish peroxidase (HRP) conjugate (b). 
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F igure 4. Scheme of the bioassay designed to test the bioavailability of the hapten-protein 
conjugate molecules attached to the SU-8 surface and scanned image obtained for  
the microarray. 
 
To evaluate the bioavailability of the rabbit serum, two formats were studied in planar. For the 
direct format immunoassay, anti-gestrinone antibody in PBS 1× at different concentrations (1, 2 and  
10 µg/mL) was immobilized on the SU-8 surface. After a blocking step with OVA or ethanolamine, 
HRP-h-G in PBS-T was spread out over the microarray using a coverslip and incubated for 10 min, 
then washed with PBS-T and water, and developed with TMB. Using this format, a positive signal was 
only observed for a protein-hapten conjugate concentration of 50 µg/mL. It was expected that the 
directly adsorbed antibody would be less efficient in reacting with the antigen that the liquid phase 
antibody due to denaturation and loss of its binding capacity. To test this, the indirect format was 
assayed (Figure 4); HRP-h-G in PBS 1× at 1, 5, 10 and 20 µg/mL was immobilized on the SU-8 planar 
surface accordingly to the procedure described above. Then, the surface was blocked with OVA and 
a 
b 
Ag+ 
Ag0 
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different dilutions of anti-gestrinone rabbit serum in PBS-T (from 1/100,000 to 1/200) were spread out, 
incubated for 10 min and washed. Finally, GAR-Au antibody diluted 1/200 in PBS-T was added, 
incubated for 10 min and washed again. Development with silver enhancer solution produced positive 
spots for anti-gestrinone serum dilutions up to 1/10,000, which corresponds to an anti-gestrinone 
antibody concentration of 100 ng/mL. The amount of specific antibody contained in the rabbit 
antiserum was determined from an aliquot of the serum that was purified by an affinity column and 
quantified by UV-vis spectrometry; the amount of specific antibody resulted in 1 mg/mL in the serum 
before any dilution. 
Under these conditions, the hapten was recognized by the antibody with high affinity. Also, several 
controls avoiding the hapten or the specific antibody were done, providing negative results, which 
confirmed the selectivity of the interaction. 
Once established the immunorecognition conditions on planar substrates, the procedure was applied 
to the biosensing on the BICELL nano-pillars. Thus, in a first stage, immobilization of HRP-h-G in 
PBS1× was monitored on the nanosensing structures. When a drop of the HRP-h-G conjugate solution 
was added for immobilization on the high-aspect ratio SU-8 nano-pillars, a strong solvent repulsion 
effect was observed due to the high hydrophobicity of the sensing material. In order to solve this,  
it was necessary to carry out a pretreatment with sulfuric acid to partially promote the opening of the 
epoxy groups, generating hydroxyl groups and increasing the surface hydrophilicity. On the other hand, 
the acidic opening of epoxy moieties precludes the covalent attachment of protein on the surface through 
their amine groups. Thus, it was necessary to reach a compromise increasing the surface hydrophilicity 
while preserving enough epoxy ring moieties able to perform protein covalent attachments. This was 
achieved with 10 s of sulfuric acid treatment. It was in agreement to other SU-8 surface hydrolysis 
procedures reported in the literature, where treatments for 30 min with chemical agents such as CAN 
(cerium ammonium nitrate) can reduce the covalent immobilization yield by around 50% [19], while 
other procedures like different chrome etchant [33] or PEG grafting [34] are necessary to totally avoid 
covalent links. Optical analysis, before and after the acidic treatment, was done using a confocal 
microscope to discard the degradation of the structure. The change in the surface wetability was clearly 
observed when adding a drop of serum dilution, as the contact angle was drastically decreased, allowing 
thus the drop infiltration inside the BICELLs. 
In order to analyze a single BICELL, a Bruker Hyperion 1000 microscope with an optical condenser 
of numerical aperture of 0.4 that provides an interrogation angle of incidence from 15° to 22° and  
a magnification of 15× was used. Signal processing techniques were applied in order to determine the 
wavenumber dip position values (w) to reduce the dip position uncertainty. Thus, first the discrete 
Fourier transform processing (DFT) from the original signal was obtained, then the high frequency 
components were rejected by applying a low-pass filter (cut off number of 0.0026 cm) and finally, the 
inverse DFT was performed to obtain the filtered signal. The signal processing was carried out 
automatically, also for determining the minimum of the signal. All measured spectra were filtered with 
the same low-pass filter. The wavenumbHU VKLIW ǻZ ZDV PRQLWRUHG WKURXJK WKH H[SHULPHQWDO
spectrometry profile to establish the sensing response of the BICELL for the protein-hapten conjugate 
immobilization, the ethanolamine blocking and later anti-gestrinone serum recognition. The trend shown 
was a negative wavenumber shift as the surface biomolecule concentration increased. For each spectrum, 
128 scans were carried out to reduce the signal-to-noise ratio and thus the wavenumber uncertainty uw. 
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Figure 5 shows the dip-positions of the interference dips as a function of gestrinone hapten and  
anti-gestrinone increasing concentrations. It was observed that for HRP-h-G concentrations above  
5 µg/mL the interference dip shift remained unchanged, indicating that the biosensing surface was 
saturated and the signal was due solely to immobilization of the hapten-protein conjugate. The total dip 
ZDYHQXPEHU VKLIW ǻZ DIWHU VDWXUDWLRQ ZDV DURXQG  FPí1. A blocking step was necessary to 
deactivate the remaining epoxy groups on the surface before starting the antibody addition and, as 
expected, the blocking step with ethanolamine 0.1 M did not yield significant signal variations. 
F igure 5. Dip shift for HRP-h-G immobilization and anti-gestrinone antibody recognition 
for the dip centered at 15,300 cmí1. Each measurement is the average of five replicates. 
 
The evaluation of the BICELLs response was carried out after incubation and washing steps to 
remove the unspecific binding for each concentration in static mode. The anti-gestrinone antibody 
recognition curve is also shown in Figure 5. A shift in the wavenumber was observed for serum 
dilutions ranging from 1/10,000 to 1/250, which corresponds to 0.1 and 4 µg/mL of antibody, for 
higher concentrations the signal remained unchanged. This suggests that anti-gestrinone antibodies can 
only bind to gestrinone hapten molecules available on the surface. Thus, specific recognition finishes 
when all the binding sites are occupied, and no surface mass accumulation is observed then. 
After anti-gHVWULQRQH VDWXUDWLRQ WKH WRWDO ǻZ ZDV KLJKHU WKDQ WKH RQH REVHUYHG IRU +53-h-G 
LPPRELOL]DWLRQ 7KHǻZ YDOXH FDOFXODWHG  FPí1) was found for a dip centered at 15,300 cmí1.  
7KH WRWDO ǻZ values for protein-hapten conjugate immobilization and antibody recognition were 
consistent with the molecular weight difference comparing the conjugate (44.2 kDa) and the antibody 
(150 kDa). Thus, if the gestrinone-to-protein labeling ratio was one, the H[SHFWHGǻZ for the antibody 
recognition should be 3.4-IROGWKHǻZREWDLQHGDIWHUSURWHLQFRQMXJDWHLPPRELOL]DWLRQ However, the 
labeling ratio usually is greater than one, which is consistent with obtaining a spectral shift higher  
than 3.4. The experimental sensitivity (ms) was also calculated from the interference dip wavenumber 
variation as a function of the antibody concentration. Thus, ms resulted in 76 cmí1/(µg/mL) and the 
anti-gestrinone limit of detection (LOD) was 0.75 ng/mL, for wres = 0.1 cmí1 (achievable in these types 
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of interferometers). The LOD was calculated as Uw/ms where Uw (Uw = 2 uw) is the expanded 
uncertainty of a coverage probability of 95% (ESI). However, the sensitivity of the device can be 
improved by reducing the pitch among nanopillars, as it has already been reported [19]. 
Finally, the affinity constant of gestrinone-anti-gestrinone was determined using the BICELLs. 
Although the reaction constants calculated using the antigen or the antibody in solid-phase can be 
considered apparent constants rather than real immunoreaction constants, it is an interesting parameter 
to know when setting up a heterogeneous biosensing assay. 
In the analyte-receptor recognition reaction, the dissociation constant is expressed as  
KD = [A][R]/[AR], where [A] is the free analyte concentration, [R] is the free receptor concentration 
and [AR] is the analyte-receptor complex concentration. At the equilibrium, KD = kd/ka, kd and ka are 
the kinetic constants for the dissociation and association process, respectively. Thus, KD can be 
considered as the reciprocal of the analyte affinity towards the receptor (the smaller the KD the higher 
the affinity). To calculate the dissociation constant, the receptor concentration is assumed to be  
[R] = [R]total ± [AR] and thus, when 50% of the binding sites are occupied ([AR] = 0.5[R]total), the 
dissociation constant is the free analyte concentration KD = [A]. Then, using the BICELLs results for 
the gestrinone-anti-gestrinone system, KD was the antibody concentration causing a response in the 
transduction equal to 50% of the total transduction change after saturation. The same determination 
was done with the results obtained previously for the BSA-anti-BSA system [14] to compare the 
obtained value with those reported in the literature [35±37]. 
Figure 6. Dip shift against antibody concentration for bovine serum albumin (BSA)-anti-BSA 
and gestrinone-anti-gestrinone systems. 
 
Figure 6 shows the different assay responses (BSA/ anti-BSA and gestrinone/anti-gestrinone) using 
the same optical transduction (SU-8 nanopillars over one micron of SiO2 and Si substrate). It can be 
seen how, when the sensing surface is saturated with antibodies, the signal level reaches a similar 
wavenumber displacement. In the case of anti-gestrinone, the slope was higher than for anti-BSA, and 
thus, the antibody concentration where 50% of the species are associated (value of KD) resulted higher 
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for anti-BSA (KD = 33 nM) than for anti-gestrinone (KD = 6 nM). Then, the affinity was calculated as 
the inverse of KD resulting in 0.03 nMí1 and 0.17 nMí1 for anti-BSA and anti-gestrinone, respectively. 
These values agree with the data reported in the literature for these systems [23,35±37] and demonstrate 
the applicability of the sensor for the determination of binding constants or biorecognition extension. 
4. Conclusions 
Highly sensitive biosensing of specific antibodies is reported in a whole rabbit serum using a cost 
effective method in terms of chip fabrication. This work presents for the first time the use of  
high-aspect ratio SU-8 nano-pillars for the calculation of antigen-antibody affinity constants, and the 
obtained values compare well with already existing data. The biosensing response was only due to 
surface modification by molecular binding during the organic films formation. The LOD of the 
BICELLs for anti-gestrinone molecule recognition was 0.75 ng/mL and the affinity constant was  
0.17 nMí1. The data reported demonstrate that the platform provides useful and reliable information 
about the biomolecules behavior, helping to set up the best conditions to develop the biorecognition 
events on the label-free sensing cells. It also demonstrates that properly biofunctionalized SU-8  
nano-pillars can be useful for antibody screening in heterogeneous samples such as whole serum. This 
can be of interest for developing sensors to detect certain diseases, where the direct measurement of 
the concentration of a specific antibody in blood serum with no further manipulation or purification 
will save time and cost. 
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Appendix  
The experimental sensitivity (ms) for the lower an-gestrinone concentrations was calculated from 
the interference dip wavenumber variation as a function of the analyte concentration. Thus, the best ms 
value was obtained for dips at 15,300 cmí1. 
In order to estimate the limit of detection (LOD), we took into account the wavenumber standard 
uncertainty (uw) during the interrogation process. This parameter can be calculated as uw2 = (wres)2/12, 
where wres is a probability distribution with constant probability density for the interferometer 
wavenumber resolution. The expanded uncertainty of a coverage probability of 95% is obtained by 
multiplying uw by a coverage factor k = 2 (Uw = 2uw), resulting Uw equal to 0.0577 cmí1 for  
a wres = 0.1 cmí1, which is the maximum resolution achievable by the interferometer Vertex 70 used 
for the experiments. The anti-gestrinone LOD was calculated as Uw/ms resulting 0.75 ng/mL for the 
dip wavenumber shifts centered around 15,300 cmí1. 
Table S1. Average neat fluorescence intensity (a.u.) obtained for Cy5 labelled protein 
microarrays immobilized on SU-8 coated and SiO2 surfaces after PBS washing (a) and after 
acidic washing (b). 
Spotted protein 
concentration (g/mL) 
SU-8 SiO2 
(a) (b) (a) (b) 
1 n.q. n.q. n.q. n.q. 
10 6,140 5,902 n.q. n.q. 
25 10,050 9,654 150 n.q. 
50 12,300 12,106 126 n.q. 
n.q.: not quantificable. 
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